Full Resistance and decreased susceptibility to carbapenems in IMP-13-producing Pseudomonas aeruginosa isolates from an outbreak

Antimicrob Agents Chemother. 2010 Mar;54(3):1381-2. doi: 10.1128/AAC.00399-09. Epub 2010 Jan 4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Argentina / epidemiology
  • Bacterial Proteins* / biosynthesis
  • Carbapenems / pharmacology*
  • Ceftazidime / pharmacology
  • Disease Outbreaks*
  • Humans
  • Microbial Sensitivity Tests / methods
  • Pseudomonas Infections / epidemiology*
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / enzymology
  • Pseudomonas aeruginosa / isolation & purification
  • beta-Lactam Resistance*
  • beta-Lactamases* / biosynthesis

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Carbapenems
  • Ceftazidime
  • beta-Lactamases